Cerenome, Inc. (CNSY)
1.93
+0.14
(+7.82%)
USD |
NASDAQ |
Oct 09, 16:00
1.94
+0.01
(+0.52%)
Pre-Market: 20:00
Cerenome Profit Margin (Quarterly) : -2.19K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.19K% |
| March 31, 2026 | -675.7% |
| December 31, 2025 | -417.9% |
| September 30, 2025 | -316.6% |
| June 30, 2025 | 85.68% |
| March 31, 2025 | -1.64K% |
| December 31, 2024 | -276.4% |
| September 30, 2024 | -197.4% |
| June 30, 2024 | -229.9% |
| March 31, 2024 | -194.5% |
| December 31, 2023 | -290.2% |
| September 30, 2023 | -259.6% |
| June 30, 2023 | -79.94% |
| March 31, 2023 | -949.6% |
| December 31, 2022 | -3.75K% |
| September 30, 2022 | -7.15K% |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | -994.1% |
| Date | Value |
|---|---|
| March 31, 2020 | -921.2% |
| December 31, 2019 | 77.44% |
| September 30, 2019 | 11.02% |
| June 30, 2019 | -750.7% |
| March 31, 2019 | -334.3% |
| December 31, 2018 | -281.9% |
| September 30, 2018 | -307.5% |
| June 30, 2018 | -254.2% |
| March 31, 2018 | -603.1% |
| December 31, 2017 | -1.25K% |
| September 30, 2017 | -1.03K% |
| June 30, 2017 | -624.3% |
| March 31, 2017 | -1.28K% |
| December 31, 2016 | -335.5% |
| September 30, 2016 | -736.5% |
| June 30, 2016 | -568.8% |
| March 31, 2016 | -400.5% |
| December 31, 2015 | -177.1% |
| September 30, 2015 | 61.65% |
| June 30, 2015 | |
| March 31, 2015 | -2.51K% |
| December 31, 2014 | -280.4% |
| September 30, 2014 | -1.81K% |
| June 30, 2014 | -1.27K% |
| March 31, 2014 | -1.01K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Ernexa Therapeutics, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Anika Therapeutics, Inc. | 10.15% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -442.0% |
| Return on Assets | -164.5% |
| Return on Invested Capital | -418.8% |
| Gross Profit Margin (Quarterly) | 63.26% |
| Operating Margin (Quarterly) | -2.20K% |
| Return on Net Operating Assets | -792.4% |